Immunotherapies are at the cutting edge of therapeutics research, offering some of the most advanced treatments for cancer and other diseases.

These treatments leverage the body’s immune system to fight disease, spanning a range of different approaches, including immune checkpoint inhibitors, adoptive cell therapies, monoclonal antibodies, oncolytic virus therapy, cancer vaccines, and immune system modulators.

However, innovations inevitably bring new challenges, and immunotherapies are no different – presenting problems of expense, treatment burden for patients, and possible side effects, in some cases severe.

A new eBook, sponsored by Sino Biological, examines the latest innovations that are driving the market and overcoming the challenges associated with these treatments.

Download this exclusive eBook to learn more about:

• Recent developments in immunotherapy drug discovery
• The risks and benefits of using immunotherapies to treat cancer
• The potential of T-cell receptor (TCR) T cell therapies
• Using AI and spatial biology to develop better immunotherapies